Suchanski, J.; Reza, S.; Urbaniak, A.; Woldanska, W.; Kocbach, B.; Ugorski, M.
Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells. Cancers 2024, 16, 389.
https://doi.org/10.3390/cancers16020389
AMA Style
Suchanski J, Reza S, Urbaniak A, Woldanska W, Kocbach B, Ugorski M.
Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells. Cancers. 2024; 16(2):389.
https://doi.org/10.3390/cancers16020389
Chicago/Turabian Style
Suchanski, Jaroslaw, Safoura Reza, Anna Urbaniak, Weronika Woldanska, Bartlomiej Kocbach, and Maciej Ugorski.
2024. "Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells" Cancers 16, no. 2: 389.
https://doi.org/10.3390/cancers16020389
APA Style
Suchanski, J., Reza, S., Urbaniak, A., Woldanska, W., Kocbach, B., & Ugorski, M.
(2024). Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells. Cancers, 16(2), 389.
https://doi.org/10.3390/cancers16020389
